Riverbridge Partners LLC trimmed its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 2.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,448,855 shares of the company's stock after selling 43,614 shares during the quarter. Riverbridge Partners LLC owned 0.88% of Option Care Health worth $50,637,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also modified their holdings of the stock. Murphy & Mullick Capital Management Corp acquired a new stake in Option Care Health during the fourth quarter worth about $26,000. Signaturefd LLC grew its holdings in shares of Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC increased its position in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after purchasing an additional 1,099 shares during the period. Public Employees Retirement System of Ohio increased its position in shares of Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after purchasing an additional 332 shares during the period. Finally, Johnson Financial Group Inc. acquired a new position in shares of Option Care Health in the fourth quarter valued at $47,000. Institutional investors and hedge funds own 98.05% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the stock. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities restated a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research report on Wednesday. JPMorgan Chase & Co. upped their price target on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Finally, Barrington Research reiterated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research note on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.
Read Our Latest Research Report on OPCH
Option Care Health Price Performance
Shares of NASDAQ:OPCH traded down $0.03 during midday trading on Friday, reaching $31.53. The company's stock had a trading volume of 3,139,850 shares, compared to its average volume of 1,880,136. The business's fifty day simple moving average is $32.08 and its 200-day simple moving average is $30.48. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.54 and a quick ratio of 1.02. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The company has a market capitalization of $5.16 billion, a P/E ratio of 25.43, a P/E/G ratio of 1.91 and a beta of 0.74.
Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. The firm had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. During the same quarter last year, the company posted $0.26 EPS. The company's quarterly revenue was up 16.3% compared to the same quarter last year. As a group, equities research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
